| Literature DB >> 28573945 |
Johan Wrammert1, Camilla Zetterlund1, Ashish Kc1,2, Uwe Ewald1, Mats Målqvist1.
Abstract
BACKGROUND: The global burden of stillbirth and neonatal deaths remains a challenge in low-income countries. Training in neonatal resuscitation can reduce intrapartum stillbirth and early neonatal mortality. Previous results demonstrate that infants who previously would have been registered as stillbirths are successfully resuscitated after such training, suggesting that there is a process of selection for resuscitation that needs to be explored.Entities:
Keywords: Neonatal resuscitation; guideline adherence; low birth weight; low-income population; video recording
Mesh:
Year: 2017 PMID: 28573945 PMCID: PMC5496083 DOI: 10.1080/16549716.2017.1322372
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Figure 1.Distribution of birth weight among control and case infants born during the Helping Babies Breathe study at a maternity health facility in Kathmandu, Nepal.
Figure 2.The total number of low birth weight (LBW) and normal birth weight (NBW) infants where resuscitation was recorded in the used data-set from a Helping Babies Breathe study in Kathmandu, Nepal.
Number of crying (n = 1062) and non-crying (n = 1191) infants according to the analysis of the video recordings related to Apgar scores at one and five minutes during the Helping Babies Breathe study at a maternity facility in Kathmandu, Nepal.
| Crying | Non-crying | ||
|---|---|---|---|
| Apgar < 4 at one minute | 8 (1) | 145 (12) | |
| Apgar ≥ 4 at one minute | 1054 (99) | 1046 (88) | < 0.01 |
| Apgar < 7 at five minutes | 32 (3) | 241 (20) | |
| Apgar ≥ 7 at five minutes | 1030 (97) | 950 (80) | < 0.01 |
Figure 3.Proportion of resuscitation interventions for non-crying low birth weight (LBW) and normal birth weight (NBW) infants during the baseline and intervention study periods of the Helping Babies Breathe study at a maternity facility in Kathmandu, Nepal.
Odds ratios (OR) adjusted for sex and place of delivery with 95% confidence intervals for a non-crying LBW baby receiving resuscitative measures compared to a non-crying NBW baby during the baseline and intervention study periods of the Helping Babies Breathe study in Nepal.
| Baseline, | Intervention, | |||||
|---|---|---|---|---|---|---|
| Adj. OR | Adj. OR | |||||
| Stimulation | ||||||
| NBW | 123 | Ref | 124 | Ref | ||
| LBW | 451 | 1.00 (0.71–1.40) | 0.99 | 22 | 0.72 (0.39–1.33) | 0.29 |
| Suction | ||||||
| NBW | 643 | Ref | 222 | Ref | ||
| LBW | 173 | 42 | 0.47 (0.21–1.02) | 0.06 | ||
| Ventilation | ||||||
| NBW | 101 | Ref | 66 | Ref | ||
| LBW | 44 | 21 | 1.87 (1.00–3.49) | 0.05 | ||
| Oxygen | ||||||
| NBW | 358 | Ref | 85 | Ref | ||
| LBW | 105 | 1.19 (0.86–1.65) | 0.30 | 23 | 1.65 (0.86–3.17) | 0.13 |
Significant values (p < 0.05) in bold.
Odds ratios (OR) adjusted for sex, place of delivery and study period with 95% confidence intervals for a non-crying LBW baby to receive resuscitative measures compared to a non-crying NBW baby during the Helping Babies Breathe study in Nepal.
| Baseline + intervention, | |||
|---|---|---|---|
| Adj. OR | |||
| Stimulation | |||
| NBW | 575 | Ref | |
| LBW | 145 | 0.93 (0.69–1.25) | 0.62 |
| Suction | |||
| NBW | 865 | Ref | |
| LBW | 215 | ||
| Ventilation | |||
| NBW | 167 | Ref | |
| LBW | 65 | ||
| Oxygen | |||
| NBW | 443 | Ref | |
| LBW | 128 | 1.28 (0.96–1.72) | 0.10 |
Significant values (p < 0.05) in bold.
| Item No. | Recommendation | Line no. or section in manuscript | |
|---|---|---|---|
| 1 | ( | Title | |
| ( | Abstract | ||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | Introduction |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | Introduction |
| Study design | 4 | Present key elements of study design early in the paper | Methods |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | Methods |
| Participants | 6 | ( | Methods |
| ( | Not a matched design | ||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | Methods |
| Data sources/measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | Methods |
| Bias | 9 | Describe any efforts to address potential sources of bias | Methods |
| Study size | 10 | Explain how the study size was arrived at | Available recordings; |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | Groups adjusted for heaping; Methods |
| Statistical methods | 12 | ( | Methods |
| ( | Crying and non-crying subgroups; Methods | ||
| ( | Only available videos were used and data on birth weight were not missing; Methods | ||
| ( | No follow-up | ||
| ( | NA | ||
| Participants | 13* | (a) Report numbers of individuals at each stage of study – e.g. numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | |
| (b) Give reasons for non-participation at each stage | All available included | ||
| (c) Consider use of a flow diagram | |||
| Descriptive data | 14* | (a) Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures and potential confounders | Methods |
| (b) Indicate number of participants with missing data for each variable of interest | NA | ||
| (c) Summarise follow-up time (e.g. average and total amount) | NA | ||
| Outcome data | 15* | Report numbers of outcome events or summary measures over time | |
| Main results | 16 | ( | |
| ( | Methods and Methods | ||
| ( | NA | ||
| Other analyses | 17 | Report other analyses done – e.g. analyses of subgroups and interactions, and sensitivity analyses | Discussion |
| Key results | 18 | Summarise key results with reference to study objectives | Discussion |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | Discussion |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | Conclusion |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | Discussion |
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | Funding |
Notes: *Give information separately for exposed and unexposed groups.
An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the websites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at http://www.strobe-statement.org.